Strongest gains on the SBF 120: Icade stock rises 2% amid oversold conditions
The office real estate company is recovering during the session following a series of record lows. It ranks among the best-performing securities on the SBF 120, in a rising Paris market.
A still timid rebound against moving averages that remain far apart
Icade stock gains 2.24% to €15.06, in the upper part of the SBF 120, while the index advances 0.58%. This recovery comes after a historic low recorded in early October and following the breach of support at €14.79 last week. The stock nevertheless remains far from its medium-term reference points: it is 4.80% below its 20-day moving average and 23.08% below its 200-day moving average. The RSI at 26.57 signals oversold conditions, and the decline has reached 11.15% over one month and 19.25% over three months.
Third-quarter results on October 20, following a pressured half-year
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Icade is publishing its quarterly results on October 20. During the H1 2026 accounts published on July 22, the real estate company had confirmed its annual guidance, with Group current net cash flow expected between €2.90 and €3.10 per share. It also noted a decline in asset value of 3.1% on a constant perimeter basis, including 2.8% on offices. On the market, the 10-year OAT is at 4.86% according to the latest Bank of France survey of October 12, 4 basis points away from its recent peak of 4.90%.
The 10-year Bund yield, for its part, is at 3.46%. Historically, Icade's share price evolves inversely to German long-term rates, a sensitivity measured over twelve years that says nothing about the future. The next appointment is on October 20.
Confirmation de la guidance annuelle 2026 avec un CFNC Groupe attendu entre 2,90 € et 3,10 € par action
Risks mentioned
Baisse de valeur du patrimoine de -3,1 % à périmètre constant, dont -2,8 % sur les bureaux
Réversion négative attendue sur les renouvellements de baux, potentiel de -7,1 % sur les loyers faciaux
Coût moyen de la dette en hausse à 1,85 %, attendu à environ 2 % fin 2026 ; ICR dégradé à 3,8x
Opportunities identified
Promesse de vente des actifs de santé au Portugal, environ 75 M€ en quote-part Icade
Acquisition des 49 % de la Tour Eqho avec un rendement supérieur à 8 %, relutive sur le CFNC
Réservations résidentielles en hausse de 11,9 % en volume et 6,4 % en valeur
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
